November 19, 2026 · Kidney international · DOI: 10.1016/j.kint.2026.10.033

Dietary sodium restriction enhances the renoprotective efficacy of endothelin-A receptor antagonism in proteinuric chronic kidney disease.

Listen to this summary

Endothelin-A receptor antagonists are emerging treatments for proteinuric chronic kidney disease, but whether dietary sodium intake alters their kidney effects was unknown. In a randomized, double-blind, placebo-controlled crossover study of 12 adults with non-diabetic proteinuric CKD, the authors found that the selective ETA antagonist BQ123 lowered blood pressure and arterial stiffness and increased kidney blood flow regardless of sodium intake, but reduced glomerular filtration rate, filtration fraction, and proteinuria only during 14 days of dietary sodium restriction (6.3 g salt/day) rather than habitual intake (13.3 g/day). These acute findings suggest that sodium restriction may enhance the kidney-protective efficacy of ERAs, though long-term benefit remains to be tested prospectively.

Dan Pugh, Gavin B Chapman, Victoria James, Alexandra Armstrong, Fiona A Chapman, Vanessa Melville, Lorraine Bruce, Jane Goddard, David J Webb, Matthew A Bailey, Neeraj Dhaun

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play